Stem Cell Trial: Older Adults Walk Farther After Treatment
From Cyrona Cell Podcast: Stem Cell Therapy in Malaysia · 1:34
Show by Sam
This episode explains a recent stem cell trial in which older adults with frailty walked farther after a single infusion, and it separates what the data show from what they do not yet show.You'll learn:- How far the highest dose group walked compared with placebo at nine months- Why the six month result did not reach statistical significance- Who took part in the phase 2b trial and how the doses were set- How mesenchymal stem cells might ease frailty, and why the mechanism is unproven- What a second, open label trial in Vietnam found and where it falls short- Why long term benefit, fewer falls and fewer hospital stays are not yet shown- Where regulators stand on stem cell products for frailtyTreat these findings as early evidence, not an approved treatment, and talk with your own doctor before considering any cell therapy.Blog Link: Stem Cell Trial: Older Adults Walk Farther After Treatment
More episodes of Cyrona Cell Podcast: Stem Cell Therapy in Malaysia
More episodes
- Stem Cells for Autism: How They Fit With Other Therapies
- Stem Cell Programs for Autism: Red Flags and Evidence
- Knee Osteoarthritis Stem Cell Study: 5-Year Results
- Stem Cells for Anoxic Brain Injury: Does Timing Matter?
- Stem Cells for Psoriasis: How They Compare With Medicines
- Japan Stem Cell Trial for Spinal Cord Injury: What It Found
- Stem Cell Therapy for Cerebral Palsy: How Rehab Fits In
- Stem Cells for Liver Disease: Fibrosis and Inflammation
- Stem Cells for CKD: Can They Help Reduce Inflammation?
- Stem Cells for Heart Failure: Blood Flow and Scarring
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.